Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for severe diastolic dysfunction in hypertensive heart disease
2010-021664-16Phase 2Completed
- Sponsor
- Solvotrin Therapeutics
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of doxycycline in diastolic dysfunction and hypertensive heart disease, sponsored by Solvotrin Therapeutics. Primary endpoints: Change in plasma MMP-2 and MMP-9 levels and Change in other collagen turnover markers. Started Aug 2010; status: completed.
02
Drugs
doxycycline
03
Conditions
diastolic dysfunctionhypertensive heart disease
Beyond the preview
Go deeper on 2010-021664-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021664-16.